Genes, Circuits and Systems by De Micheli, Giovanni
Genes, Circuits and Systems
Circuits & System Workshop, 2005
Giovanni De Micheli
Centre Systèmes Intégrés
G. De Micheli -- ISCAS 2005 2
What we know:
A (nearly) complete list of the 
genes
What we don’t know:
Gene functions and interactions
DNA microarray:
Disruptive technology for uncovering gene 
function on a global scale
Gene Expression Analysis
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The global picture
n Measuring biological samples
n Biosensors --> Circuits
n Analyzing biological information
n Software tools --> Signal Processing
n Modeling and controlling interactions
n Laboratory on a chip --> Systems
Bio-discovery uses technologies and tools similar to those 
used with traditional circuits and systems
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The micro-array operation
a b c
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Three phases
n Micro-array design and fabrication
n Micro-array hybridization and readout
n After sample preparation
n Micro-array data analysis
n This technologies exists since the mid-nineties
n Ubiquitous in top-level research
n Still virtually unused in clinical practice
n Plenty of opportunities for refinement
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Established micro-array 
fabrication technologies
n DNA spotting on glass substrates
n Relatively inexpensive and reproducible
n Pat Brown (Stanford)
n Mask-based (semiconductor-like) fabrication
n Oligonucleotides (25mers)
n High-density, high cost
n Affymetrix (Mountain view)




n Changes in the capacitive 
behavior of an electrode/ 
solution bio-sensing interface
n Integrated optical sensors
n Molecular light absorbance
n Visible, UV
n Optical arrays
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Electrical measurements
n Dedicated on chip circuitry for capacitance 
measurements 
[Schienle - Infineon 2004]
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Industrial Technology roadmap
[STM]
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Objectives
n Clinical analysis
n Discover signatures of diseases
n Discover effect of medications
n Bio-discovery
n Gene regulatory networks
n Pharmacogenomics
n Design drugs with direct impact on genetic 
features
G. De Micheli -- ISCAS 2005 15
X. Chen & P.O. Brown et al
Molecular Biology of the Cell
Vol. 13, 1929-1939, June 2002
Identifying Disease Genes
G. De Micheli -- ISCAS 2005 16
Disease Subtype Classification
Today
n Patient side: 
n More efficient treatment, i.e. 
avoid side effects of useless 
therapy
n Health Care System side: 
n Efficient use of information, 
time and resources
Diversity of gene expression 
in adenocarcinoma of the lung 
Garber et Al. PNAS November 20,
2001 vol 98 n.24 13784-13789
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Understanding of Bio-mechanisms
Today
n Experiments are non-
pathological varying 
environmental condition
n i.e. how gene expression 
of endothelial cells 
changes with blood 
pressure variation
Endothelial cell Diversity revealed by global expression profiling, 
Chi, Chang, Haraldsen, PNAS, September 16 2003, vol100, n.19, 10623-10628
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Data analysis
n To find common patterns in gene 
expression levels
n Upregulated/downregulated genes
n To group similar patterns
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The curse of dimensionality
n Underdetermined system




















Cases (10’s – 100’s)
A Typical Clinical Study
































columns Focuses on 
subsets
Biclustering
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Bi-clustering algorithms
n Several approaches
n d-biclustering [Cheng & Church 2000]
n Heuristic
n P-Clustering [Wang et al. 2002] 
n Heuristic
n d-Pclustering [Yoon et al. 2004]
n Exact
n Advantages:
n Capture relevant subspaces
n Capture coherence and fluctuation
n Disadvantages:
n Computationally hard
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Computational Challenge
n Find all relevant maximal biclusters
n Rank them according to some metric
n E.g. Mean score residue (MSR)
n Exploit methods for large scale data handling
n BDDs and ZDDs
n Use implicit representation to avoid full set 
representation and to support operations
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Set operations with ZDDS
n ZDDs support well recursive operations
n Like union and intersection
n Recursive algorithms are w.c. exponential
n But linear with  representation size
n Representation size grows mildly with problem size












Our method (no ZBDD)
Time (sec.)
# biclusters foundYeast cell cycle data 
(Tavazoie et al., 1999) [Yoon 2004]
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Keypoints
n Clustering is a key difficult problem to solve
n Methods based on implicit set representations 
(e.g. with ZDDs) can cope with large data set
n For all practical purposes, micro-array data 
can be efficiently processed today
n Outstanding issues
n Biological validation of data
n Statistical analysis of results
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GO – The 3 Ontologies





n Directed acyclic graphs
n Each node is uniquely labeled 
n Ex:  GO:000xxxx
n Flat description files
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Biological process
Development Cellular process Physiological process
morphogenesis
organogenesis









GO - Direct Acyclic Graph
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GO - Flat Files
GO:0000067$Gene_Ontology ; GO:0003673
@part_of:biological_process ; GO:0008150
@is_a:cellular process ; GO:0009987
@is_a:cell growth and/or maintenance ; GO:0008151 ; synonym:cell 
physiology @is_a: physiological process ; GO:0007582
@is_a:cell proliferation ; GO:0008283
@part_of:cell cycle ; GO:0007049 ; synonym:cell-division cycle
@part_of:DNA replication and chromosome cycle ; GO:0000067
@is_a:physiological process ; GO:0007582
@is_a:cell growth and/or maintenance ; GO:0008151 ; synonym:cell 
physiology @is_a: cellular process ; GO:0009987
@is_a:cell proliferation ; GO:0008283
@part_of:cell cycle ; GO:0007049 ; synonym:cell-division cycle
@part_of:DNA replication and chromosome cycle ; GO:0000067
@part_of:cellular_component ; GO:0005575
@part_of:molecular_function ; GO:0003674
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GoMiner - Positioning in Ontology 
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Cluster validation by GO
n A cluster with genes in a single category 
n Clear biochemical meaning 
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[Nardini et al. 2004]
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Goal
n Correlate clinical traits with genetic data
n Example:
n Biopsy genetic analysis and imaging data
n Objective: 
n Better diagnosis of diseases and response to 
medication
CAD -- Computer Aided Diagnosis
























0 1 0 1 1 1 1 1 1 0
Radiological Data
Coding into a categorical imaging 
scoring schema 
[Nardini, RSNA 2004]




















IMAGE:740604ISG20 || interferon stimulated gene 20kDa-1.02 -2.34 1.44 0.57 -0.13 0.12 0.34 -0.51
IMAGE:767176TNFSF13 || tumor necrosis factor (ligand) superfamily, member 13-0.52 -4.06 -0.29 0.71 1.0 -0.67 0.22 -0.09
IMAGE:366315LOC93343 || **hypothetical protein BC011840-0.25 -4.08 0.06 0.13 0.08 0.06 -0.08 -0.05
IMAGE:235135ITGA4 || integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)-1.375 -1.605 0.155 -0.015 0.035 -0.035 0.505 -0.865
Coding into an expression value 
scoring schema
Genomic  Data




































1 0 1 0 0 1 0 1 0
Necrosis: 
N=0, Y=1










1 1 1 0 0 1 1 0 1
IMAGE:740604ISG20 || interferon stimulated gene 20kDa-1.02 -2.34 1.44 0.57 -0.13 0.12 0.34 -0.51 0.47
IMAGE:767176TNFSF13 || tumor necrosis factor (ligand) superfamily, member 13-0.52 -4.06 -0.29 0.71 1.0 -0.67 0.22 -0.09 0.1
IMAGE:366315LOC93343 || **hypothetical protein BC011840-0.25 -4.08 0.06 0.13 0.08 0.06 -0.08 -0.05 -6.56E-09
IMAGE:235135ITGA4 || integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)-1.375 -1.605 0.155 -0.015 0.035 -0.035 0.505 -0.865 1.325
IMAGE:784109SGCE || sarcoglycan, epsilon-0.4 -3.13 0.62 1.91E-08 0.56 -0.42 -0.91 0.12
IMAGE:83011RPS4Y || **ribosomal protein S4, Y-linked-0.83 -1.3 0.65 -2.07 0.31 -2.16 0.88 -2.37 0.36
IMAGE:814942SMCY || Smcy homolog, Y chromosome (mouse)-1.99 -2 0.21 -2.15 1.25 -2.7 0.38 -2.71 0.1
IMAGE:782679DBY || DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide, Y chromosome-1.29 -0.99 0.34 -1.35 -0.03 -0.95 0.41 -1.01 0.42
















































































Trait 1 0 1 0 1 1 1 1 1 1
Trait 2 1 0 1 0 0 1 0 1 0
Trait 3 1 1 1 0 1 1 1 1 1
Trait 4 1 1 1 1 0 0 1 1 0
Trait 5 0 1 0 1
IMAGE:740604ISG20 || interferon stimulated gene 20kDa-1.02 -2.34 1.44 0.57 -0.13 0.12 0.34 -0.51 0.47
IMAGE:767176TNFSF13 || tumor necrosis factor (ligand) superfamily, member 13-0.52 -4.06 -0.29 0.71 1.0 -0.67 0.22 -0.09 0.1
IMAGE:366315LOC93343 || **hypothetical protein BC011840-0.25 -4.08 0.06 0.13 0.08 0.06 -0.08 -0.05 -6.56E-09
IMAGE:235135ITGA4 || integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)-1.375 -1.605 0.155 -0.015 0.035 -0.035 0.505 -0.865 1.325
I :784109SGCE || sarcoglycan, epsilon-0.4 -3.13 0.62 1.91E-08 0.56 -0.42 -0.91 0.12
IMAGE:83011RPS4Y || **ribosomal protein S4, Y-linked-0.83 -1.3 0.65 -2.07 0.31 -2.16 0.88 -2.37 0.36
I :814942SMCY || Smcy ho olog, Y chromosome (mouse)-1.99 -2 0.21 -2.15 1.25 -2.7 0.38 -2.71 0.1
IMAGE:782679DBY || DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide, Y chromosome-1.29 -0.99 0.34 -1.35 -0.03 -0.95 0.41 -1.01 0.42
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Co-clustering
n Unsupervised cluster search method in higher 
dimensional spaces
n Correlate data and provide qualitative 
information about pathology
n Results:
n Method was applied to renal carcinoma with good 
correlation
n Outstanding issue:
n Scoring of radiological data
n Can this be automated?
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Immunohistochemical
Automated Quantification
n Acquiring quantitative and qualitative 
information from immuno-stains
ß
n Automated image processing methods to 
standardize IHC analysis
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Example of IHC images
EGFR/erb-B receptors positivity (in carcinoma cells) as brown stain
Negative carcinoma cells and other cells in the sample as blue stain





n A closed loop system
n Identification
n Optimum control
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Gene regulatory networks
Example: Phage l decision circuit
[MYERS 2003]
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Gene regulatory networks
Example: Phage l asynchronous model
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Gene regulatory networks
Circadian cycle in homo sapiens
[KEGG]
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Summary and conclusions
n Genomic information has been exploding
n Its effective use is still limited
n Application areas include:
n Clinical medicine, pharmaceutics, biology
n Technologies include:
n Modeling, abstraction, circuit design, data analysis, 
dedicated languages, optimal control
CAS researchers master these technologies and can 
widen their horizons to these application areas
